María José Sayas-Lloris

6PUBLICATIONS
80CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 31, 2026
Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.

|Feb 11, 2026
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Gaspar Aspas Requena, Pau Montesinos, Emilie Bérard

|Oct 13, 2025
Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Pau Montesinos, Rebeca Rodríguez-Veiga, Juan Miguel Bergua

|Aug 14, 2025
Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Laura Torres-Miñana, Blanca Boluda, Antonio Solana-Altabella

|Mar 13, 2025
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study.

Blanca Boluda, Rebeca Rodriguez-Veiga, Claudia Sargas

|Sep 02, 2022
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.

Tamara Castaño-Bonilla, Eva Barragán, Claudia Sargas

Pageof 1

Frequent Collaborators

5 joint publications

Pau Montesinos

5 joint publications

David Martinez-Cuadron

5 joint publications

Lorenzo Algarra Algarra

5 joint publications

Mar Tormo